Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report

被引：0
|
作者：
Alexandra-Ioana Pușcașu
Fabien Moinard-Butot
Delphine Antoni
Roland Schott
Laura Somme
机构：
[1] Institut de Cancérologie Strasbourg Europe,Medical Oncology Department
[2] Institut de Cancérologie Strasbourg Europe,Radiation Oncology Department
来源：
Journal of Medical Case Reports | / 17卷
关键词：
Acrometastasis; Oligometastatic lung adenocarcinoma; Phalanx metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 19 条
  • [1] Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report
    Puscasu, Alexandra-Ioana
    Moinard-Butot, Fabien
    Antoni, Delphine
    Schott, Roland
    Somme, Laura
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [2] The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features
    Ma, Zelin
    Zhang, Yang
    Deng, Chaoqiang
    Fu, Fangqiu
    Deng, Lin
    Li, Yuan
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (01): : E73 - E85
  • [3] Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
    Barbie, David A.
    Spira, Alexander
    Kelly, Karen
    Humeniuk, Rita
    Kawashima, Jun
    Kong, Shengchun
    Koczywas, Marianna
    CLINICAL LUNG CANCER, 2018, 19 (06) : E853 - E859
  • [4] Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
    Mirallas, Oriol
    Bosch-Schips, Marc
    Pardo, Nuria
    Aubanell, Anton
    Salcedo-Allende, Maria Teresa
    Callejo, Ana
    Iranzo, Patricia
    Tabernero, Josep
    Felip, Enriqueta
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: a case report
    Jeffrey Mathew Boby
    Nurul Nadia Mohd Ghazali
    Anita Mani
    Mathew George
    Journal of Medical Case Reports, 16
  • [6] Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: a case report
    Boby, Jeffrey Mathew
    Ghazali, Nurul Nadia Mohd
    Mani, Anita
    George, Mathew
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [7] Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value
    Wang, Hua
    Schabath, Matthew B.
    Liu, Ying
    Stringfield, Olya
    Balagurunathan, Yoganand
    Heine, John J.
    Eschrich, Steven A.
    Ye, Zhaoxiang
    Gillies, Robert J.
    CLINICAL LUNG CANCER, 2016, 17 (04) : 271 - 278
  • [8] Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
    Li, Jia-Xin
    Li, Run-Ze
    Ma, Lin-Rui
    Wang, Peng
    Xu, Dong-Han
    Huang, Jie
    Li, Li-Qi
    Tang, Ling
    Xie, Ying
    Leung, Elaine Lai-Han
    Yan, Pei-Yu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Kirsten rat sarcoma viral oncogene homolog G12C mutant advanced non-small-cell lung cancer treated with MEK1/2 inhibitor trametinib: a case report
    Jiang, Ya
    Liu, Xin
    Lv, Dong-Lai
    Zhao, Xi-Long
    ANTI-CANCER DRUGS, 2022, 33 (01) : E752 - E755
  • [10] Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: A case report
    Rossing H.H.
    Grauslund M.
    Urbanska E.M.
    Melchior L.C.
    Rask C.K.
    Costa J.C.
    Skov B.G.
    Sørensen J.B.
    Santoni-Rugiu E.
    BMC Research Notes, 6 (1)
12